ATP Inhibits Breast Cancer Migration and Bone Metastasis through Down-Regulation of CXCR4 and Purinergic Receptor P2Y11
ATP released by bone osteocytes is shown to activate purinergic signaling and inhibit the metastasis of breast cancer cells into the bone. However, the underlying molecular mechanism is not well understood. Here, we demonstrate the important roles of the CXCR4 and P2Y11 purinergic receptors in media...
Main Authors: | Xiaowen Liu, Manuel A. Riquelme, Yi Tian, Dezhi Zhao, Francisca M. Acosta, Sumin Gu, Jean X. Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4293 |
Similar Items
-
Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells
by: Yang M, et al.
Published: (2019-05-01) -
Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4
by: Ying Wang, et al.
Published: (2020-01-01) -
F-Type ATP Synthase Assembly Factors Atp11 and Atp12 in Arabidopsis
by: Zhikun Duan, et al.
Published: (2020-10-01) -
High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy
by: Bobae Shim, et al.
Published: (2018-11-01) -
CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
by: Wang Y, et al.
Published: (2018-09-01)